Form 1 SurveyMonkey for NCORP

2017 NCORP Annual Meeting

OMB No.: 0925-0642
Expiration Date: 5/31/2020

Public reporting burden for this collection of information is estimated to average 10 minutes per response, including the time
for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and
reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to, a
collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden
estimate or any other aspect of this collection of information, including suggestions for reducing this burden to: NIH, Project
Clearance Branch, 6705 Rockledge Drive, MSC 7974, Bethesda, MD 20892-7974, ATTN: PRA (0925-XXXX). Do not return
the completed form to this address.

2017 NCORP Annual Meeting

General Questions

Please select the best response for each question.

1. What is your role in NCORP? (Check all that apply)
PI or Investigator

Clinical / Research Staff

NCORP Administrator

NCI Staff

CCDR Lead
Other (please specify)

1

2. What type of NCORP grantee do you represent?
Community Site

Research Base

Minority/Underserved Community Site

Not Applicable

2017 NCORP Annual Meeting

Day 1 - Monday August 28 2017

For each session, please select the response which best represents the extent to which you agree or disagree with the
statements below.

2

3. The following sessions (titles and presenters below) provided useful
information for my NCORP role.
Agree

Neutral

Disagree

NCORP Year in Review
(Worta McCaskill-Stevens,
MD, MS)
Keynote: Cancer Control
in the 21st Century (Otis
Brawley, M.D.)
Science of CCDR (Ann
Geiger, Ph.D., M.P.H.)
Communicating Costs in
Oncology: Advocacy
Perspective (Shelly Fuld
Nasso)
Communicating Costs in
Oncology: Research
Perspective (Ya-Chen
Tina Shih, Ph.D.)
TMIST: Clearing the Fog
(Jeannine Brant, Ph.D.)
NCI Legislative Update:
Congressional Budget
Process and Resulting
NIH Funding
NCORP Research Bases
Town Hall

3

4. Was the breakout session you attended informative and relevant to
your NCORP role?
Agree

Neutral

Disagree

N/A: DID NOT ATTEND

Financial Toxicity and
Cancer Care Costs: Are
You Ready to Talk About
It?
Insurance and Clinical
Trials
Minority Health
Disparities: Diversity
Considerations
Registration Credentialing
Repository
(RCR)/Delegation of Task
Log (DTL) Update
Navigating the CIRB
Protocol Review Process:
Tips for Success

5. Was the breakout session useful and relevant to your NCORP role?
Agree
Neutral
Disagree

6. Any additional comments/feedback on the day 1 plenary or breakout
sessions?

2017 NCORP Annual Meeting

4

Day 2 - Tuesday August 29 2017

For each session, please select the response which best represents the extent to which you agree or disagree with the
statements below.

7. The following sessions (titles and presenters below) provided useful
information for my NCORP role.
Agree

Neutral

Disagree

adiation Therapy Quality
Assurance in Clinical
Trials: Why and How
(Dave Followill, Ph.D.)
CTEP Update (Meg
Mooney, M.D.)
CIRB Update: Spotlighting
Local Issues (Laura
Covington)
Considerations and
Process for Applying for
an NCI RFA (Michael
Small, Ph.D.)
Grants Administration
(Sean Hine)

8. Was the breakout session you attended informative and relevant to
your NCORP role?
Agree

Neutral

Disagree

N/A: DID NOT ATTEND

New and Upcoming
NCORP CCDR Studies
Overcoming Accrual
Challenges: It Can be
Done!
Clinical Trials and Elderly
Accrual: Has There Been
Any Progress?
Social Media for NCORP:
Promotion and
Recruitment

5

9. Any additional comments/feedback on the day 2 plenary or breakout
sessions?

2017 NCORP Annual Meeting

Overall Meeting

Please select the response which best represents the extent to which you agree or disagree with the statements below.

10. There was sufficient time to interact with my colleagues.
Agree

Neutral

Disagree

11. There was sufficient time to interact with NCI staff.
Agree

Neutral

Disagree

12. There was sufficient time for audience questions and dialogue on
session topics.
Agree

Neutral

Disagree

13. Was the length of the NCORP Investigator Meeting?
Too long
Too short
Just right

6

14. Overall, how would you rate this meeting?
Excellent
Good
Fair
Poor

15. What session(s) did you find most useful and relevant?

16. What improvements or changes would you recommend for future
NCORP Annual meetings?

17. What other topics would you like to see covered in future NCORP
Annual meetings or NCORP webinars?

7